Compare HDB & SYK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HDB | SYK |
|---|---|---|
| Founded | 1994 | 1941 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 166.1B | 140.0B |
| IPO Year | 2002 | 1994 |
| Metric | HDB | SYK |
|---|---|---|
| Price | $28.23 | $335.85 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 12 |
| Target Price | N/A | ★ $431.08 |
| AVG Volume (30 Days) | ★ 6.3M | 1.7M |
| Earning Date | 01-01-0001 | 04-30-2026 |
| Dividend Yield | ★ 1.36% | 1.04% |
| EPS Growth | N/A | ★ 8.25 |
| EPS | N/A | ★ 8.40 |
| Revenue | N/A | ★ $25,116,000,000.00 |
| Revenue This Year | N/A | $9.86 |
| Revenue Next Year | $8.84 | $8.39 |
| P/E Ratio | ★ $18.92 | $40.23 |
| Revenue Growth | N/A | ★ 11.16 |
| 52 Week Low | $28.05 | $328.23 |
| 52 Week High | $79.62 | $404.87 |
| Indicator | HDB | SYK |
|---|---|---|
| Relative Strength Index (RSI) | 19.92 | 26.59 |
| Support Level | N/A | N/A |
| Resistance Level | $37.18 | $375.26 |
| Average True Range (ATR) | 0.53 | 8.49 |
| MACD | -0.31 | -5.66 |
| Stochastic Oscillator | 4.56 | 12.76 |
HDFC Bank Ltd is an Indian bank. It operates in the following segments: Treasury, Retail banking, Wholesale banking, and Other banking business. The maximum revenue for the company is generated from its Retail banking segment, which serves retail customers through its branch network and other channels. This segment raises customer deposits and provides loans and other services to customers using different product groups. Its other operations include providing wholesale banking services to corporates, government entities, and other enterprises, generating income from its treasury operations, and performing para-banking activities such as offering credit cards, debit cards, etc. Geographically, the company generates a majority of its revenue from its operations in India.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.